Matches in Wikidata for { <http://www.wikidata.org/entity/Q91993165> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- Q91993165 description "article scientifique publié en 2019" @default.
- Q91993165 description "artículu científicu espublizáu n'ochobre de 2019" @default.
- Q91993165 description "scientific article published on 01 October 2019" @default.
- Q91993165 description "wetenschappelijk artikel" @default.
- Q91993165 description "наукова стаття, опублікована 1 жовтня 2019" @default.
- Q91993165 name "Antidrug antibody formation during tumor necrosis factor α inhibitor treatment of severe psoriatic patients in the real-life practice" @default.
- Q91993165 name "Antidrug antibody formation during tumor necrosis factor α inhibitor treatment of severe psoriatic patients in the real-life practice" @default.
- Q91993165 type Item @default.
- Q91993165 label "Antidrug antibody formation during tumor necrosis factor α inhibitor treatment of severe psoriatic patients in the real-life practice" @default.
- Q91993165 label "Antidrug antibody formation during tumor necrosis factor α inhibitor treatment of severe psoriatic patients in the real-life practice" @default.
- Q91993165 prefLabel "Antidrug antibody formation during tumor necrosis factor α inhibitor treatment of severe psoriatic patients in the real-life practice" @default.
- Q91993165 prefLabel "Antidrug antibody formation during tumor necrosis factor α inhibitor treatment of severe psoriatic patients in the real-life practice" @default.
- Q91993165 P1433 Q91993165-D5B84B9F-DD6C-47D2-8BDC-F7219CC5F209 @default.
- Q91993165 P1476 Q91993165-765B4EEB-6109-4FAA-973D-2560AA2E8116 @default.
- Q91993165 P2093 Q91993165-25ED3495-8B3D-427A-8A28-DCF2F30E6542 @default.
- Q91993165 P2093 Q91993165-37CE0FFB-0C2A-4390-A5FA-6E3DC36BFE3A @default.
- Q91993165 P2093 Q91993165-656EB5D6-916C-480F-8CF6-52C80D980776 @default.
- Q91993165 P2093 Q91993165-B9FE6EB2-588E-45D2-AEDC-D98AA0E03083 @default.
- Q91993165 P2093 Q91993165-BD476EFF-2EE3-43D3-B3CF-851E889ABFE8 @default.
- Q91993165 P2093 Q91993165-D3BC89DA-E8A9-4C64-87A2-FCD281CCDEEF @default.
- Q91993165 P2860 Q91993165-0B625FC7-A38D-4BF5-A87D-1D3F5C7983C5 @default.
- Q91993165 P2860 Q91993165-38282852-AD0F-4FEC-BC77-F19B204C7C14 @default.
- Q91993165 P2860 Q91993165-3AAFDE83-9811-48D5-9E6B-C7EB1BF137D6 @default.
- Q91993165 P2860 Q91993165-43391EA3-ECDA-4FB7-917F-059C42D0C85C @default.
- Q91993165 P2860 Q91993165-4C8DA5CA-80E7-4363-A0D5-3A922077C92D @default.
- Q91993165 P2860 Q91993165-6EC5F764-D33E-44E6-A2DD-A21EE38578FF @default.
- Q91993165 P2860 Q91993165-774BFEE4-3B9E-42A1-A41A-52B19F3D9B53 @default.
- Q91993165 P2860 Q91993165-7944519E-B196-4DA2-B530-5B94BA11DFF6 @default.
- Q91993165 P2860 Q91993165-90912540-25A3-43A2-A3B2-61B154C2A280 @default.
- Q91993165 P2860 Q91993165-9F75E3AF-DB02-4BF7-8A0E-0E6AAEE8535B @default.
- Q91993165 P2860 Q91993165-BF73D092-E38D-48B3-BDC0-FC95C1F7FC3B @default.
- Q91993165 P2860 Q91993165-C5D4FDE8-096A-4B58-BCE5-199C0F6A221D @default.
- Q91993165 P2860 Q91993165-C966CC4E-260E-494C-A664-1C61F81B3427 @default.
- Q91993165 P2860 Q91993165-ED5D2FA2-B131-44D8-871E-0B5B8E2B67D5 @default.
- Q91993165 P304 Q91993165-30DED38E-0060-4F65-9E97-10902E78C4D7 @default.
- Q91993165 P31 Q91993165-DCC37507-56E6-45A7-BE13-DE2F88A48245 @default.
- Q91993165 P356 Q91993165-236544B8-BB6A-4E9C-808A-1A15BABAF375 @default.
- Q91993165 P433 Q91993165-6D52E54C-1DAE-475D-A9AB-33DB3694ABD5 @default.
- Q91993165 P478 Q91993165-6C655543-2885-402B-B13E-36935F777BB8 @default.
- Q91993165 P577 Q91993165-04DC6DDF-9564-41B8-945A-52CB60F4B593 @default.
- Q91993165 P698 Q91993165-ED6F29B0-F6D7-4DC1-B5FF-9EA5E4DA7039 @default.
- Q91993165 P932 Q91993165-5B53C2A1-73F2-49F9-A3A8-4ED161A00F56 @default.
- Q91993165 P356 ADA.2019.89507 @default.
- Q91993165 P698 31839776 @default.
- Q91993165 P1433 Q22965552 @default.
- Q91993165 P1476 "Antidrug antibody formation during tumor necrosis factor α inhibitor treatment of severe psoriatic patients in the real-life practice" @default.
- Q91993165 P2093 "Eszter Nagy" @default.
- Q91993165 P2093 "Fanni Rencz" @default.
- Q91993165 P2093 "Hajnalka Jókai" @default.
- Q91993165 P2093 "Krisztina Herszényi" @default.
- Q91993165 P2093 "Péter Holló" @default.
- Q91993165 P2093 "Valentin Brodszky" @default.
- Q91993165 P2860 Q35692116 @default.
- Q91993165 P2860 Q38151757 @default.
- Q91993165 P2860 Q38212907 @default.
- Q91993165 P2860 Q38473460 @default.
- Q91993165 P2860 Q42340099 @default.
- Q91993165 P2860 Q44750379 @default.
- Q91993165 P2860 Q46389803 @default.
- Q91993165 P2860 Q46605499 @default.
- Q91993165 P2860 Q46728001 @default.
- Q91993165 P2860 Q48234568 @default.
- Q91993165 P2860 Q80473541 @default.
- Q91993165 P2860 Q83753671 @default.
- Q91993165 P2860 Q84585183 @default.
- Q91993165 P2860 Q84898634 @default.
- Q91993165 P304 "589-594" @default.
- Q91993165 P31 Q13442814 @default.
- Q91993165 P356 "10.5114/ADA.2019.89507" @default.
- Q91993165 P433 "5" @default.
- Q91993165 P478 "36" @default.
- Q91993165 P577 "2019-10-01T00:00:00Z" @default.
- Q91993165 P698 "31839776" @default.
- Q91993165 P932 "6906958" @default.